• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew Winton

Location
Boston, MA
Summary
The estimated net worth of Matthew Winton is at least $303,925 dollars as of 13 Feb 2026. Matthew Winton is the COO of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. stock worth about $184.7K. Matthew Winton is the Chief Commercial and Business of CervoMed Inc. and owns shares of CervoMed Inc. (CRVO) stock worth about $119.2K.
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All Insider Reports
All Insider Reports

Notify me when Matthew Winton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Matthew Winton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INZY Inozyme Pharma, Inc. Coo $184,675 01 Jul 2025
CRVO CervoMed Inc. Chief Commercial and Business $119,250 +$117,130 +5525% 11 Feb 2026

Insider Transactions Reported by Matthew Winton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.